Mumbai, India

Subramani N Iyer

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subramani N Iyer. Retrieved from https://idiyas.com/inventor/subramani-n-iyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Subramani N Iyer: Innovator in Antimalarial and Antiviral Compounds

Introduction

Subramani N Iyer is a notable inventor based in Bombay, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antimalarial and antiviral properties. His work has implications for public health and disease management.

Latest Patents

Subramani N Iyer holds a patent for "9-substituted compounds of 3.alpha." This patent describes compounds of formula I, where the substituted R has specific meanings that confer antimalarial and antiviral activity. His innovative approach to compound design showcases his expertise in the field.

Career Highlights

Iyer is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His role at Hoechst has allowed him to engage in cutting-edge research and development, contributing to advancements in drug discovery.

Collaborations

Throughout his career, Iyer has collaborated with esteemed colleagues, including Bindumadhavan Venugopalan and Chintamani P Bapat. These collaborations have fostered a productive research environment, leading to significant scientific advancements.

Conclusion

Subramani N Iyer's contributions to the field of medicinal chemistry, particularly through his patented compounds, highlight his role as an innovator in the fight against infectious diseases. His work continues to inspire future research in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…